# OnCo record paper-checkmate-577-nejm-2021 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-checkmate-577-nejm-2021/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-checkmate-577-nejm-2021" ;
  schema:name "CheckMate 577: adjuvant nivolumab in resected oesophageal or gastro-oesophageal junction cancer"@en ;
  schema:description "A year of nivolumab after chemoradiotherapy and surgery doubled disease-free survival in patients with oesophageal or junctional cancer who still had residual tumour at surgery, the first adjuvant therapy to work in this setting."@en ;
  schema:url <https://onco.cc/key-papers/paper-checkmate-577-nejm-2021/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/NEJMoa2032125>, <https://pubmed.ncbi.nlm.nih.gov/33789008/> ;
  schema:sameAs <https://doi.org/10.1056/NEJMoa2032125> ;
  schema:datePublished "2021"^^xsd:gYear ;
  schema:author "Kelly RJ, Ajani JA, Kuzdzal J, et al." ;
  onco:cancers <https://onco.cc/cancers/oesophageal-squamous-cell-carcinoma/> ;
  onco:drugs <https://onco.cc/drugs/nivolumab/> ;
  onco:trials <https://onco.cc/trials/checkmate-577/> ;
  onco:journals <https://onco.cc/journals/nejm/> .